Management of post-menopausal osteoporosis: something new on the horizon?
Brandi
M L
ML
Department of Internal Medicine, University of Florence, Florence, Italy. m.brandi@dmi.unifi.it
D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology*; D002118:Calcium / Q000494:pharmacology / Q000627:therapeutic use; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D009942:Organometallic Compounds / Q000494:pharmacology / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D019379:Teriparatide / Q000494:pharmacology / Q000627:therapeutic use; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use; D014807:Vitamin D / Q000494:pharmacology / Q000627:therapeutic use
D004164:Diphosphonates; D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate; D019379:Teriparatide; D014807:Vitamin D; D002118:Calcium